Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
Bausch + Lomb Acquires Dry Eye Diagnostic Company Trukera Medical
Bausch + Lomb announced July 23 that it had acquired dry eye diagnostic company Trukera Medical from its private equity owner, AccelMed Partners, and other shareholders. No financial details were d...
Eyenovia, Senju Will Collaborate on Chronic Dry Eye Candidate with Optejet Microdoser
Eyenovia, of New York, announced July 23 that it had entered into a collaboration agreement with Japan’s Senju Pharmaceutical to develop Senju’s corneal epithelial wound healing candidate, SJP-0035...
Samsara Says First SING IMT for AMD Has Been Implanted in China
Samsara Vision, of Far Hills, New Jersey, announced July 22 that the first SING IMT procedure for age-related macular degeneration (AMD) had been completed in China. The SING IMT, which stands for ...
2024 Octane Meeting Delves Into Practice Management Issues
The 2024 Octane Ophthalmology Tech Forum changed up its program from previous years, putting more focus on practice management and moving to a new location: the VEA Newport Beach, in Newport Beach,...
New OTC Eye Lubricants Available from AbbVie, Ocusoft
AbbVie has introduced two new preservative-free lubricant eye drop products—Refresh Tears PF and Refresh Relieva PF Xtra. AbbVie, of North Chicago, Illinois, said the new products feature a soft-sq...
Cancer Company TME Pharma Plans to Spin Off NOX-E36 for Eye Disease
Germany’s TME Pharma, a clinical-stage cancer company, announced July 22 that it planned to spin off its asset NOX-E36 to advance it for eye disease. NOX-E36 is an L-stereoisomer RNA aptamer inhibi...
Advisory Panel Recommends Orphan Drug Status for SIFI’s Polihexanide in Fungal Keratitis
Italy’s SIFI announced July 22 that a European advisory panel had recommended orphan drug designation for its polihexanide eye drop for fungal keratitis. The Committee for Orphan Medicinal Products...
Beacon Appoints Lance Baldo, MD, as Chief Executive Officer
Beacon Therapeutics announced July 24 that it had named Lance Baldo, MD, as chief executive officer, effective Aug. 12, 2024. Most recently, Baldo served as chief medical officer at Freenome, an ea...
Multitude of Novel Glaucoma Surgery Devices to Drive Procedure Growth
The goal of a growing number of companies entering the already crowded glaucoma device market is to provide surgical treatment options with greater safety and effectiveness. Thirty-six products are...
Q2-2024 Ophthalmic Deals Total More Than $1.6 Billion, Include One Strategic Purchase
Ophthalmic deals in Q2-2024 reached over $1.6 billion and involved 19 transactions. This compares with $7.0 billion from 25 transactions in Q2-2023 and $2.0 billion from 17 transactions in Q1-2024....
Digital Enhancements Reshape $3.7 Billion Ophthalmic Diagnostic Equipment Market
Ongoing investments in digital products designed to enhance ophthalmic diagnostic equipment and associated outputs are signaling a shift away from the fast-paced equipment releases of the early 200...
Market Scope Appoints Kristen Harmon Ingenito as CEO
Market Scope announced July 11 that Kristen Harmon Ingenito, MBA, had been appointed chief executive officer. Dave Harmon, founder of Market Scope, will serve as chief financial officer and data se...
Past News Stories
EssilorLuxottica Acquires Majority Stake in Diagnostics Maker Heidelberg
Eyewear conglomerate EssilorLuxottica announced July 17 that it had agreed to acquire an 80 percent stake in Heidelberg Engineering, a leader in ophthalmic diagnostic imaging. Financial details wer...
IOP-Lowering Goggles Developed by John Berdahl, MD, Gain De Novo Certification for Marketing
Balance Ophthalmics has gained US FDA de novo classification for its FSYX Ocular Pressure Adjusting Pump (FSYX OPAP) system, a goggles and pump system designed to lower intraocular pressure (IOP) i...
Select US FDA Approvals and Clearances in June 2024
The US FDA granted four clearances through the ophthalmic device division using the 510(k) pathway in June 2024, according to the agency’s database. Alcon gained clearance for its much-anticipated ...
Beacon Leads Latest Ophthalmic Fundraising with $170 Million in Series B
Beacon Therapeutics led recent ophthalmic fundraising efforts with $170 million in Series B funding to advance its candidates for retinal disease. Financing announced in the past four weeks totaled...
ANI to Acquire Alimera Sciences, Maker of Iluvien and Yutiq, for $381 Million
ANI Pharmaceuticals announced June 24 that it would acquire Alimera Sciences, maker of Iluvien and Yutiq, in a deal worth $381 mil-lion up front. The deal is expected to close in late Q3-2024, the ...
Ophthalmic Chain in Colorado Closing All Six Clinics, Citing COVID-19 Financial Fallout
Rocky Mountain Eye Center, based in Pueblo, Colorado, announced on its website that it will close all of its six clinics on July 31, saying the practice was unable to recover from the financial fal...
2024-2025 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
Bausch + Lomb Adds Dry Eye Supplement to Fast-Growing Consumer Segment
Bausch + Lomb is expanding its fast-growing consumer segment with the launch of a nutritional supplement to combat the signs and symptoms of dry eye. The supplement is called Blink NutriTears. The ...
Emerging Companies Pursuing Ophthalmic Indications, July 2024
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
Ophthalmic Devices to be Included in FDA TAP Accelerator Program
The US FDA announced July 1 that it was expanding its TAP pilot program in October to include ophthalmic devices, as well as radiological health devices. The voluntary program, officially named the...
Clinical Trial Updates for Ophthalmic Candidates, July 2024
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
Blinking Boosts Visual Perception Rather than Hindering It, Study Shows
Researchers at the University of Rochester have found that blinking plays a critical role in visual perception, in addition to maintaining eye health. Their research was published in April 2024 in ...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.